[1]
“Impact of local treatment on survival outcomes in patients with metastatic lung cancer with oligoprogression undergoing immunotherapy”, Swiss Med Wkly, vol. 156, no. 4, p. 4790, Apr. 2026, doi: 10.57187/4790.